215 related articles for article (PubMed ID: 15833992)
21. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis.
Young ST; Paulson EK; Washington K; Gulliver DJ; Vredenburgh JJ; Baker ME
AJR Am J Roentgenol; 1994 Dec; 163(6):1385-8. PubMed ID: 7992734
[TBL] [Abstract][Full Text] [Related]
22. Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy.
He H; Cai C; Charnsangavej C; Theriault RL; Green M; Quraishi MA; Yang WT
Can Assoc Radiol J; 2015 Nov; 66(4):356-62. PubMed ID: 26165625
[TBL] [Abstract][Full Text] [Related]
23. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
[TBL] [Abstract][Full Text] [Related]
24. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
[TBL] [Abstract][Full Text] [Related]
25. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma.
Feinstein EG; Marr BP; Winston CB; Abramson DH
Arch Ophthalmol; 2010 Mar; 128(3):319-23. PubMed ID: 20212202
[TBL] [Abstract][Full Text] [Related]
26. [Pulse inversion ultrasonography with ultrasonography contrast media (levovist) in the evaluation of hepatic metastasis].
Giovagnoni A; Martegani A; Aiani L; Ligabue G; Romagnoli R; Del Favero C
Radiol Med; 2001 Mar; 101(3):111-7. PubMed ID: 11402947
[TBL] [Abstract][Full Text] [Related]
27. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
[TBL] [Abstract][Full Text] [Related]
28. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
[TBL] [Abstract][Full Text] [Related]
29. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
[TBL] [Abstract][Full Text] [Related]
30. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns--correlation study with contrast-enhanced CT.
Zhou X; Luo Y; Peng YL; Cai W; Lu Q; Lin L; Sha XX; Li YZ; Zhu M
Radiology; 2011 Jul; 260(1):274-81. PubMed ID: 21467250
[TBL] [Abstract][Full Text] [Related]
31. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer.
Taira N; Ohsumi S; Takabatake D; Hara F; Takashima S; Aogi K; Takashima S; Inoue T; Sugata S; Nishimura R
Jpn J Clin Oncol; 2008 Jun; 38(6):419-25. PubMed ID: 18502779
[TBL] [Abstract][Full Text] [Related]
34. Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer.
Kang KA; Jang KM; Kim SH; Kang TW; Cha DI
Clin Radiol; 2017 Jun; 72(6):473-481. PubMed ID: 28258741
[TBL] [Abstract][Full Text] [Related]
35. MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.
Giovagnoni A; Terilli F; Ercolani P; Paci E; Piga A
AJR Am J Roentgenol; 1994 Nov; 163(5):1093-7. PubMed ID: 7976881
[TBL] [Abstract][Full Text] [Related]
36. Is Non-Contrast CT Adequate for the Evaluation of Hepatic Metastasis in Patients Who Cannot Receive Iodinated Contrast Media?
Jee HB; Park MJ; Lee HS; Park MS; Kim MJ; Chung YE
PLoS One; 2015; 10(7):e0134133. PubMed ID: 26218533
[TBL] [Abstract][Full Text] [Related]
37. Utility of dual phase liver CT for metastatic melanoma staging and surveillance.
Winkler N; Rezvani M; Heilbrun M; Shaaban A
Eur J Radiol; 2013 Dec; 82(12):2189-93. PubMed ID: 24041437
[TBL] [Abstract][Full Text] [Related]
38. Detection of liver metastases from pancreatic cancer using FDG PET.
Fröhlich A; Diederichs CG; Staib L; Vogel J; Beger HG; Reske SN
J Nucl Med; 1999 Feb; 40(2):250-5. PubMed ID: 10025831
[TBL] [Abstract][Full Text] [Related]
39. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
[TBL] [Abstract][Full Text] [Related]
40. Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up.
Brennan SB; Sung JS; Dershaw DD; Liberman L; Morris EA
Radiology; 2011 Oct; 261(1):92-9. PubMed ID: 21852565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
